Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 2:8:100344.
doi: 10.1016/j.ejro.2021.100344. eCollection 2021.

Comparison of the safety and efficacy of PABO above or below the ovarian artery during cesarean delivery in patients with coexisting placenta accreta and placenta previa

Affiliations

Comparison of the safety and efficacy of PABO above or below the ovarian artery during cesarean delivery in patients with coexisting placenta accreta and placenta previa

Hiroyuki Tokue et al. Eur J Radiol Open. .

Abstract

Purpose: To determine the effect of ovarian arteries on the use of prophylactic abdominal aortic balloon occlusion (PABO) in patients with coexisting placenta accreta and placenta previa.

Methods: Thirty-two pregnant women with coexisting placenta accreta and placenta previa treated with PABO in our hospital during 2013-2020 were retrospectively analyzed. The patients were divided into two groups: one with infra-renal abdominal aortic balloon occlusion above the ovarian artery (Group A, n = 15) and the other with occlusion below the ovarian artery (Group B, n = 17). Medical records and relevant imaging of all patients were reviewed. All Cesarean deliveries were scheduled and we decided to perform hysterectomy based on the surgical findings.

Results: Patients in both groups were similar in terms of age, gravidity history, and status of placenta. Regarding their outcomes, estimated blood loss was not significantly different in both groups, although it was lower in Group B than in Group A (3949.5 vs. 4333.8 ml). The other tested parameters did not show any difference. The uterus was preserved in 13 (41%) patients. No access-related or balloon occlusion-related complications occurred in either group.

Conclusions: PABO was safe. However, the balloon location (above or below the ovarian arteries) did not influence the outcomes. Further evaluation and prospective studies are required to evaluate the safety and efficacy of balloon occlusion above or below the ovarian artery in patients with coexisting placenta accreta and placenta previa.

Keywords: CTCAE, common terminology criteria for adverse events; EBL, estimated blood loss; MAP, morbidly adherent placenta; Ovarian artery; PABO, prophylactic abdominal aortic balloon occlusion; Placenta accreta; Placenta previa; Prophylactic abdominal aortic balloon occlusion (PABO); US, ultrasound.

PubMed Disclaimer

Conflict of interest statement

The authors report no declarations of interest.

Figures

Fig. 1
Fig. 1
Coexisting placenta accreta and placenta previa. Sagittal MR image (T2-weighted image) showing the abnormal placental tissue abutting the bladder wall (arrow).
Fig. 2
Fig. 2
Prophylactic balloon occlusion of the intra-abdominal aorta in patients with coexisting placenta accreta and placenta previa. (a) A digital subtraction abdominal aortogram was performed via the right femoral approach prior to the placement of an aortic occlusion balloon. Angiography showed the renal artery opening (circle), ovarian arteries (arrows), and position of the common iliac artery bifurcation (star). (b) In Group A, the occlusion balloon was placed between the renal and ovarian arteries. (c) In Group B, the occlusion balloon was placed between the ovarian artery and bifurcation.

Similar articles

Cited by

References

    1. Fan Y., Gong X., Wang N., Mu K., Feng L., Qiao F., Chen S., Zeng W., Liu H., Wu Y., Zhou Q., Tian Y., Li Q., Yang M., Li F., He M., Beejadhursing R., Deng D. A prospective observational study evaluating the efficacy of prophylactic internal iliac artery balloon catheterization in the management of placenta previa-accreta: a STROBE compliant article. Medicine. 2017;96(45):e8276. - PMC - PubMed
    1. Goh W.A., Zalud I. Placenta accreta: diagnosis, management and the molecular biology of the morbidly adherent placenta. J. Matern. Fetal. Neonatal. Med. 2016;29(11):1795–1800. - PMC - PubMed
    1. Shih J.C., Liu K.L., Shyu M.K. Temporary balloon occlusion of the common iliac artery: new approach to bleeding control during cesarean hysterectomy for placenta percreta. Am. J. Obstet. Gynecol. 2005;193(5):1756–1758. - PubMed
    1. Peng W., Shen L., Wang S., Wang H. Retrospective analysis of 586 cases of placenta previa and accreta. J. Obstet. Gynaecol. 2020;40(5):609–613. - PubMed
    1. Wei Y., Luo J., Luo D. Comparison of efficacy between internal iliac artery and abdominal aorta balloon occlusions in pernicious placenta previa patients with placenta accrete. Gynecol. Obstet. Invest. 2019;84(4):343–349. - PubMed

LinkOut - more resources